Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis
Clinical trial NCT02745080 · COMPLETED
Trial details
- NCT number
- NCT02745080
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-03
- Primary completion
- 2019-12-30
- Enrollment
- 853
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.